PhD in Immunology

The University of Nairobi is a leading African institution founded in 1970 and located in Kenya's capital, Nairobi. With around 84,000 students including roughly 1,200 international learners, the university offers a broad range of programs across health sciences, engineering, business, humanities, and development studies. Its long history and strong research profile make it a hub for regional scholarship and professional training.

UoN emphasizes applied research and community engagement, hosting institutes that tackle environmental, health, and development challenges. International students benefit from a multicultural campus, partnerships with international organizations, and hands-on learning opportunities that connect theory to practice. Support services through the International Office help with admissions, visas, and orientation to Kenyan academic and social life.

On-campus housing is available with varying costs and options; applying well in advance is recommended to secure accommodation. The university's position in Nairobi provides access to internships, NGOs, and a growing tech and business sector, making it attractive for students seeking meaningful research, regional networks, and practical experience in East Africa.

The PhD in Immunology at the University of Nairobi is a 3-year program that helps students become experts in Immunology. It is designed for students who want to pursue careers in research, academia, or public health. The program is taught in English and takes place on campus.

Students in this program study topics like immunology, microbiology, and molecular biology. They also learn about research methods, laboratory techniques, and data analysis. The program includes hands-on experiences like laboratory work, seminars, and journal clubs, which help students develop their research skills.

Graduates of this program can work as immunologists, research scientists, laboratory managers, or university lecturers. They can find jobs in hospitals, research institutions, or pharmaceutical companies, where they contribute to the development of new treatments and vaccines.